TOPLINE:
The DermSat-7 questionnaire shows promise as a way to measure patient satisfaction with acne treatment, especially in areas of effectiveness and overall satisfaction.
METHODOLOGY:
Treatment satisfaction is a key factor in the therapeutic success of an acne care regimen, but data on measures of satisfaction are limited, and there is a need for a patient-reported outcome measure to assess patient satisfaction with acne treatment.
The cross-sectional study included 142 adults aged ≥ 18 years (mean age, 25.1 years) who were using medication for acne. They completed the questionnaire between July 2022 and May 2023. The researchers assessed the structural validity, construct validity, and internal consistency of the DermSat-7, a 7-item dermatology-specific acne questionnaire, using confirmatory factor analysis and Cronbach alpha values.
The DermSat-7 includes seven questions assessing the effectiveness of treatment (three questions), convenience of treatment (three questions), and overall satisfaction (one question). Patients rated each item on a 5-point scale, from not satisfied (1) to completely satisfied (5), on the basis of previous 7 days.
The most common treatments were topical antibiotics, topical retinoids, oral isotretinoin, and benzoyl peroxide; 52.8% of patients were using two or more medications.
TAKEAWAY:
The DermSat7 showed internal consistency on measures of effectiveness and convenience, with Cronbach alpha values of 0.89 and 0.80, respectively.
